Harmony Biosciences Holdings (HRMY) Net Income (2019 - 2025)
Historic Net Income for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $50.9 million.
- Harmony Biosciences Holdings' Net Income rose 1035.3% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 4438.4%. This contributed to the annual value of $117.5 million for FY2024, which is 178.37% up from last year.
- Per Harmony Biosciences Holdings' latest filing, its Net Income stood at $50.9 million for Q3 2025, which was up 1035.3% from $39.8 million recorded in Q2 2025.
- Harmony Biosciences Holdings' Net Income's 5-year high stood at $87.9 million during Q3 2022, with a 5-year trough of -$9.6 million in Q3 2021.
- For the 5-year period, Harmony Biosciences Holdings' Net Income averaged around $30.6 million, with its median value being $29.5 million (2023).
- Data for Harmony Biosciences Holdings' Net Income shows a peak YoY increase of 5238518.52% (in 2021) and a maximum YoY decrease of 60392.88% (in 2021) over the last 5 years.
- Over the past 5 years, Harmony Biosciences Holdings' Net Income (Quarter) stood at $19.1 million in 2021, then skyrocketed by 154.53% to $48.5 million in 2022, then crashed by 72.81% to $13.2 million in 2023, then surged by 62.84% to $21.5 million in 2024, then skyrocketed by 136.86% to $50.9 million in 2025.
- Its Net Income was $50.9 million in Q3 2025, compared to $39.8 million in Q2 2025 and $45.6 million in Q1 2025.